Project Title: Phase IV open label study of fixed artemisininlnaphthoquine (ARCO®) therapy to determine safety, tolerability, pharmacokinetics and efficacy in adults and children with uncomplicated P.falciparum malaria in Tanzania

Project Description: XX XX Read more

Principal Investigator : Salim Abdulla

Department Name : BRCT

Time frame: (2013-10-01) - (2016-09-30)

Funding Partners
Medicines for Malaria Venture (MMV) (Normal)
External Collaborating Partners
None added yet.